|
A-Z Listing of ACDC Program Topics
|
Note: PDF documents on this site were created using Adobe Acrobat 5.0 or later. If you are using an earlier version of Adobe Acrobat Reader (4.x or less), document functionality may be reduced. |
For Health Care Professionals
Guidelines and Recommendations
- Regulations For Communicable Disease Reporting (B-82, Revised 02/00)
-
Admissions & Infection Control in Hospitals and Healthcare Organizations
- Explains which diseases in healthcare facilities require special restrictions
- Details discharge regulations for patients with Salmonella, Shigella or Tuberculosis
- Gives regulations for communicable diseases in skilled nursing facilities
- Explains regulations regarding communicable diseases in intermediate care facilities
- Details infection control and employee health policies in healthcare facilities and home health agencies
-
A public health procedural manual, about diseases, and when to report them.
The report serves the following purposes:
- Provides important information on each disease
- Gives legal requirements related to the disease
- Procedures
- Investigation Forms
Recent updated sections include the
following:
- Immunization Procedures
- Hepatitis A
- LAIV
- Meningococcal Conjugate Vaccine (MCV4)
- Storage and Handling of Common Immunobiologics (changes in storage of LAIV)
- Other Prophylactic Agents (changes in Immune Globulin section for hepatitis A and varicella)
- References
-
Infection Control Guidelines for Prevention & Control
of Multidrug-Resistant Organisms in Long-Term Medical Care
Facilities.
(3-24-08)
- Laboratory Reporting List (8-14-07)
- Important Changes in Reportable Diseases (See Last Page For List) (7-18-07)
- Bioterroism Agents: Photos and Information for Clinicians
- Communicable Disease Control Manual B-73 Update: Kawasaki & Scabies (4/30/07)
- Terrorism Agent Information and Treatment Guidelines for Hospitals & Clinicians - New Brucellosis Chapter! (4-24-07)
- Communicable Disease Control Manual B-73: Pertussis - Update for Standard Procedures in Nasopharyngeal Specimen Collection (3-07)
- Specimen Submission Guidelines for Suspected Botulism (excluding Infant Botulism) (Note: Testing the patient's serum for toxin after treatment with antitoxin is no longer recommended. If continued toxin production is suspected, please consult with ACDC again - 2/5/07)
- Guidelines for the Prevention & Control of Scabies in L.A. County Health Care Facilities (Updated To Post 8/3/06; Initial Post on 6/30/06)
- Varicella Outbreak Control & Provisional Recommendations (4/20/06)
- Norovirus Control Measures - LA County Department of Public Health (Updated 12/1/06)
- Hospital Pandemic Influenza Guidelines (03-1-06)
- Hospital "DVC Plan" Guidelines
- Information for Infection Control Practitioners on Respiratory Syncytial Virus (RSV) (1/25/06)
- Guidelines for Reducing the Spread of Staph/CAMRSA in Non-Healthcare Facilities (12/28/04)